Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $106,916 - $128,055
798 Added 4.34%
19,174 $2.81 Million
Q3 2022

Nov 08, 2022

SELL
$126.59 - $161.18 $575,604 - $732,885
-4,547 Reduced 19.84%
18,376 $2.45 Million
Q2 2022

Aug 12, 2022

SELL
$141.59 - $168.66 $123,183 - $146,734
-870 Reduced 3.66%
22,923 $3.58 Million
Q1 2022

May 13, 2022

BUY
$129.64 - $160.7 $1.35 Million - $1.67 Million
10,390 Added 77.52%
23,793 $3.71 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $1.27 Million - $1.82 Million
9,864 Added 278.72%
13,403 $1.75 Million
Q4 2020

Feb 12, 2021

SELL
$140.71 - $165.05 $3.26 Million - $3.83 Million
-23,200 Reduced 86.76%
3,539 $584,000
Q2 2020

Aug 11, 2020

BUY
$95.68 - $121.88 $1.3 Million - $1.66 Million
13,639 Added 104.11%
26,739 $2.95 Million
Q4 2019

Feb 06, 2020

BUY
$117.65 - $153.73 $1.54 Million - $2.01 Million
13,100 New
13,100 $1.96 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.